DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic

Luca Bertero1, Luisella Righi2, Giammarco Collemi3

  • 1Pathology Unit, Department of Medical Sciences, University of Turin and Città della Salute e della Scienza University Hospital, Turin, Italy; Department of Neuropathology, Institute of Pathology, University Hospital of Heidelberg, Heidelberg, Germany.

Summary

DNA methylation profiling effectively diagnoses malignant pleural mesothelioma (MPM) by distinguishing it from other cancers and reactive conditions. This molecular approach aids in accurate MPM diagnosis, even with challenging cases.

Related Concept Videos